SAB BIOTHERAPEUTICS, INC. (SABSW) Operating income 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) annual operating income history from SEC filings — each fiscal year as reported.
-$49.0MFY2025 · since FY2020: $20.6M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | -14.1% |
| FY2024 | -$42.9M | -12.7% |
| FY2023 | -$38.1M | -31.7% |
| FY2022 | -$28.9M | -115.9% |
| FY2021 | -$13.4M | -165.2% |
| FY2020 | $20.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating marginSABSW Operating cash flowSABSW Free cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW Shareholders’ equitySABSW overview →